MedPath
FDA Approval

Escitalopram

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
January 5, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Escitalopram(5 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Denton Pharma, Inc. DBA Northwind Pharmaceuticals

Denton Pharma, Inc. DBA Northwind Pharmaceuticals

Denton Pharma, Inc. DBA Northwind Pharmaceuticals

080355546

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Escitalopram

Product Details

NDC Product Code
70934-957
Application Number
ANDA202389
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 5, 2023
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
HYPROMELLOSE 2910 (15000 MPA.S)Inactive
Code: 288VBX44JCClass: IACT
Code: 5U85DBW7LOClass: ACTIMQuantity: 5 mg in 1 1
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
© Copyright 2025. All Rights Reserved by MedPath